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Human embryonic stem cells (hESCs) have been proposed as a
promising source of cell replacement therapy for spinal cord injury.
To this end, several pioneering attempts have been made to devel-
op efﬁcient culture conditions for the generation of oligodendro-
cytes from hESCs [1–3]. However, further studies are still needed
to develop more optimal culture conditions in which hESCs could
recapitulate features of normal oligodendrocytic development.
Spinal cord oligodendrocytes mainly arise in a restricted ventral
region of the caudal neural tube (motor neuron progenitor [pMN]
domain) under the combined inﬂuences of locally acting morpho-
genetic signals and subsequent expression of different sets of pat-
terning genes [4–6]. A recent report showed that oxygen tensionon behalf of the Federation of Euro
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+82 2 3290 3507.also differentially inﬂuences the proliferation of human
CD133+Nestin+ neural precursors and their differentiation into oli-
godendrocytes [7].
In addition to the patterning molecules and environmental
cues, different extracellular matrices (ECM) play important roles
in the differentiation of various cell types. Thus, directed differen-
tiation using appropriate ECM substrata may be an important fac-
tor that promotes the differentiation of oligodendrocytes from
hESCs. Vitronectin (VN) is a multifunctional ECM glycoprotein
and is involved in the differentiation of diverse cell types in
embryonic and adult tissues [8]. In the developing mouse neural
tube, VN is expressed in the notochord and the ﬂoor plate, the
same place where sonic hedgehog (Shh), a ventralizing factor, is
produced [9]. Previous studies showed that VN promotes the gen-
eration of spinal motor neurons by synergistically interacting with
Shh, both in explants and neuroepithelial cell cultures of chick
embryo spinal cord [10]. Considering that both oligodendrocytes
and motor neurons are derived from a common pool of progeni-
tors in the pMN domain of the spinal cord [5,6], VN is a possible
candidate to promote the differentiation of spinal cord oligoden-
drocytes as well as motor neurons. In this context, the present
study was designed to investigate whether oligodendrocytic dif-
ferentiation can be efﬁciently promoted by VN during neural dif-
ferentiation of hESCs.pean Biochemical Societies.
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2.1. Human ESC culture and differentiation
Maintenance of hESC lines (Miz-hES4 and Miz-hES6) and gener-
ation of human embryoid bodies (hEBs) were carried out as we de-
scribed previously [11]. All experimental procedures involving
hESCs were approved by the KoreanMinistry of Health andWelfare
and the Stem Cell Research Center (IRB number 24). To induce neu-
ral patterning, we treated day 2-hEBs with 10 lM retinoic acid (RA)
(Sigma–Aldrich, St. Louis, MO), 500 ng/ml Shh (R&D Systems, Min-
neapolis, MN), 1 lg/ml noggin (R&D Systems) and/or 5 lg/ml VN
(BD Biosciences, San Jose, CA) for an additional 6 days in glial
restriction medium (GRM) previously used to differentiate hESCs
to glial cells [1]. To increase the number of oligodendrocyte precur-
sor cells (OPCs), hEBs (treated with Shh, RA, noggin, and VN for
6 days) were dissociated and plated on VN-coated plate at a density
of 1.25  104 cells/cm2 and cultured for 8 days in GRM containing
10 ng/ml basic ﬁbroblast growth factor (bFGF) and/or platelet-de-
rived growth factor (PDGF, R&D Systems). To further differentiate
these cells into more mature oligodendrocytes, we cultured the
OPCs in GRM in the presence or absence of the following survival
factors: 5 ng/ml neurotrophin 3 (NT-3), 100 ng/ml insulin-like
growth factor-I (IGF-I), and 1 lg/ml cyclic adenosine 30,50-mono-
phosphate (cAMP).
2.2. RNA extraction and semi-quantitative RT-PCR
Total RNA was isolated using Trizol (Invitrogen, Carlsbad, CA),
and cDNA was synthesized from 1 lg of total RNA using the Super-
Script III ﬁrst-strand synthesis system (Invitrogen). The cDNA was
used as the template in a polymerase chain reaction (PCR) using
AccuPower PCR-Premix (Bioneer, Daejeon, Korea). Primer se-
quences and reaction conditions used in this study are listed in
supplemental Table 1. PCR products were conﬁrmed by ethidium
bromide staining following 1% agarose gel electrophoresis. Relative
band intensities were determined using an image analyzer (Auto-
Chemi Bioimaging System, UVP Inc., Upland, CA). The levels of tar-
get mRNA expression were normalized based on the signals
obtained from glyceraldehyde-3-phosphate dehydrogenase (GAP-
DH) mRNA expression.
2.3. Bromodeoxyuridine (BrdU) Incorporation
The proliferation capacity of OPCs was evaluated by exposing
cells to 10 lM BrdU for 24 h at day 6 of the OPC expansion period.Table 1
Primer sets used in the RT-PCR analysis of differentiation markers.
Gene 50 Primer 30 Primer
SOX17 agcgcccttcacgtgtacta cttgcacacgaagtgca
AFP tgaaaaccctcttgaatgcc tcttgcttcatcgtttg
Mixl1 ggtaccccgacatccactt tgagtccagctttgaac
T agccactgcttccctgagac aggctggggtactgact
GATA4 ctcccctggcaaaacaagag tgccgtgtcttagcagt
Otx2 caacagcagaatggaggtca ctgggtggaaagagaag
HoxB1 tcagaaggagacggaggcta gtgggggtgttaggttc
HoxB4 gtgcaaagagcccgtcgtcta cc cgtgtcaggtagcggtt
HoxB5 attatggcagtggcagctct gcctcgtctatttcggt
HoxC5 tcggggtgcttccttgtagc ttcgtggcagggactat
HoxB6 aactccaccttccccgtcac cttctgtctcgccgaac
HoxC8 tttatggggctcagcaagagg tccacttcatccttcgg
Oct4 cgtgaagctggagaaggagaagctg aagggccgcagcttaca
Nanog ccaaaggcaaacaacccact tgaattgttccaggtct
NG2 agtgtggtggacccagactc cattgacacccctagcc
CNPase cgctctacttcggctggttcctgac ttgggtgtcacaaagag
PLP ccatgccttccagtatgtcatc gtggtccaggtgttgaa
MBP atccaagtacctggccacag cccagctaaatctgctc
GAPDH agccacatcgctcagacacc gtactcagcggccagcaThe cells were then ﬁxed with methanol for 15 min on ice, dena-
tured in 2 N HCl for 45 min at room temperature and then incu-
bated for 15 min with 0.1 M sodium borate (pH 8.5). The cells
were incubated overnight at 4 C with rat anti-BrdU antibody
(Accurate Chemical, Westbury, NY; 1:100) in phosphate buffered
saline (PBS) with 5% goat serum and incubated for 1.5 h with the
appropriate Alexa Fluor secondary antibody (Molecular Probes, Eu-
gene, OR).
2.4. Immunostaining analysis
Cells were ﬁxed in 4% paraformaldehyde (PFA) in PBS. EBs ﬁxed
in 4% PFA were saturated with 20% sucrose, embedded in O.C.T.,
compound (Tissue Tek, Sakura Finetek, Torrance, CA), and sec-
tioned at 9-lm intervals using a Cryostat (model CM 3050S, Leica
Microsystems, Bannockburn, IL). Immunostaining and alkaline
phosphatase activity staining was performed as previously de-
scribed [11,12]. Antibodies used in this study are listed in supple-
mental Table 2. Appropriate ﬂuorescence-tagged secondary
antibodies (Jackson ImmunoResearch Laboratories, West Grove,
PA) were used for visualization. Quantitation was performed using
Axiovision Version 2.4 software (Carl Zeiss). Randomly selected
ﬁelds (n = 15–20) from a minimum of three independent experi-
ments were analyzed using a 10 objective of the Carl Zeiss Apo-
tome optical sectioning microscope. Total cell number was
counted using 40,6-diamidino-2-phenylindole (DAPI). Results are
expressed as the percentage of positive cells (mean ± S.D.) out of
total cells.
2.5. Vitronectin staining
Tissue sections of human embryonic spinal cord (14 weeks)
were obtained from the Department of Pathology, College of Med-
icine, Seoul National University and ﬁxed in 4% PFA in PBS. The
tissue sections were deparafﬁnized, rehydrated, and boiled in
sodium citrate buffer (10 mM sodium citrate) for 30 min. The sec-
tions were immunolabeled with antibodies against VN (Molecular
Innovations, Novi, MI) and counterstained with Mayer’s
hematoxylin.2.6. Statistical analysis
Results were analyzed using a one-way ANOVA and the Bonfer-
roni’s test procedure for multiple comparisons with the appropri-
ate control. P values less than 0.05 were judged to be signiﬁcant.Annealing temperature (C) Product size (bp)
gat 57 246
cag 55 492
caa 55 335
gga 60 500
cgt 60 422
ctg 60 429
tga 62 218
gtagtg 62 161
gaa 62 340
ggg 62 290
acg 62 340
ttctg 62 318
catgttc 60 250
ggttg 60 398
agt 62 535
ggcagaga 62 300
gtaaatgt 60 249
agg 62 298
tcg 60 302
Table 2
Antibodies used for immunostaining of differentiation markers.
Marker Vendor Dilution factor
SSEA-4 R&D Systems 1:50
OCT4 Santa Cruz 1:500
Nanog R&D Systems 1:100
HNF3b DSHB 1:10
SOX17 R&D Systems 1:100
AFP Sigma 1:500
GATA4 Santa Cruz 1:400
T R&D Systems 1:100
Pax6 Chemicon 1:2000
Nestin R&D Systems 1:200
Otx2 R&D Systems 1:100
HB9 DSHB 1:10
Olig1 Chemicon 1:400
Olig2 R&D Systems 1:100
O4 R&D Systems 1:400
NG2 Chemicon 1:400
CNPase Chemicon 1:200
BrdU Accurate 1:200
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3.1. VN is expressed in ventral part of developing human spinal cord
Currently, ﬁbronectin and laminin are the most widely used
ECM molecules for in vitro generation of various neural cell types,
including oligodendrocytes. Since previous studies demonstrated
that VN is expressed in the ventral region of the embryonic chick
spinal cord [9,10], we ﬁrst examined the expression pattern of hu-
man VN (hVN) in the developing human spinal cord. Immunohisto-
chemical analysis using an anti-hVN antibody revealed that VN
immunoreactivities were present in the dorsal root ganglion and
ventral region of the developing spinal cord (14 weeks; Fig. 1A–
C). Thus, hVN exhibits a similar expression pattern as chick VN,
suggesting that VN may inﬂuence the differentiation of hESC into
oligodendrocyte in vitro.3.2. Noggin promotes neurectodermal differentiation during EB
formation
hESCs are pluripotent cells capable of differentiating into a vari-
ety of cell types, including non-neural cells. Thus we ﬁrst at-
tempted to promote neural differentiation of hESCs beforeFig. 1. Expression of VN in the developing human spinal cord. (A) Immunohistochemica
are shown at higher magniﬁcation. Note VN expression in the dorsal root ganglion (B) aassessing the effect of VN on oligodendrocytic differentiation. For
this purpose, hESC were differentiated in the presence of either
RA or noggin, both of which are known to promote neural differen-
tiation of hESCs [13,14]. Unlike the untreated control-EBs (Fig. 2A),
RA- or noggin-treated EBs displayed a compact morphology with a
smooth surface and no prominent outer layer, a morphological
characteristic of neurospheres (Fig. 2B and C). Particularly, cystic
EBs that were frequently found in control conditions (Fig. 2A,
arrowheads) were rarely seen in RA-treated EBs (RA-EBs) and al-
most absent in noggin-treated EBs (noggin-EB). Semi-quantitative
RT-PCR analysis showed that the neurectodermal genes, Sox1/Nes-
tin, were more highly expressed in control- and noggin-EBs than in
RA-EBs, although an early neurectodermal marker, Pax6, was ex-
pressed at similar levels in RA- and noggin-EBs (Fig. 1D). Impor-
tantly, noggin-EBs exhibited an efﬁcient downregulation of
mesendodermal genes (Hnf3b, Sox17, AFP, MixL1, GATA4, and T),
suggesting that noggin preferentially differentiated hESCs into
neural lineages. This neurogenic effect of noggin was further con-
ﬁrmed by immunostaining. In noggin-EBs, the number of cells
expressing both Pax6 and Nestin was profoundly increased
(Fig. 2H and L: 13% versus 75% of total cells in control- and nog-
gin-EBs, respectively), whereas mesendodermal cells were rarely
found, as compared to control-EBs (Fig. 2E–G and I–K).
3.3. Caudalization and ventral patterning of hESC-derived
neurectoderm
Given that spinal cord oligodendrocytes are derived from the
caudal region of the neural tube, we reasoned that in vitro caudal-
ization of hESC-derived neuroepithelial cells could be achieved
through exposure to caudalizing factors in the presence of neuro-
genic factors. To test this hypothesis, we treated hESCs with RA,
a powerful caudalizing factor, together with noggin during EB for-
mation, and analyzed the expression proﬁle of different Hox genes
that are highly expressed in the caudal domain of the neural tube
[15,16]. Remarkably, combined treatment with RA and noggin (RA/
noggin) dramatically repressed the expression of Otx2, the
forebrain and midbrain marker, and concomitantly upregulated
the expression of the Hox genes (Fig. 3A). Consistent with the
RT-PCR results, Otx2+ cells were abundant in control-EBs but
hardly observed in RA/noggin-EBs (Fig. 3B and C). Conversely,
HB9+ cells were not found in control-EBs but were easily detectable
in RA/noggin-EBs (Fig. 3B). In addition, many of HB9/TuJ1l staining for VN in developing human spinal cord. (B, C) The two boxed areas in (A)
nd ventral spinal cord (C).
Fig. 2. Neurectodermal differentiation during EB formation. (A–C) Phase contrast images of differentiated EBs (arrowheads, cystic EBs). Scale bars, 300 lm. (D) RT-PCR
analysis of genes associated with primary embryonic germ layers. *P < 0.05 versus control (n = 3). (E–L) Immunostaining for deﬁnitive and primitive endoderm (HNF3b/AFP/
GATA4/Sox17), mesoderm (T), and neurectoderm (Pax6/Nestin).
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these cells were not seen in control-EBs (Fig. 3C, right panels).
We next examined the patterning effect of Shh on hESC-derived
neurectoderm by evaluating the expression of genes associated
with positional identities of the cells along the dorsoventral axis
of the spinal cord. Interestingly, only RA-treated EBs (both
RA + noggin [R/N] and Shh + RA + noggin [S/R/N]) showed a broad
range of expression for the dorsoventral genes of spinal cord
(Nkx2.2, Olig2, Pax6, and Pax7) (Fig. 3D). Although both RA/noggin-
and Shh/RA/noggin-EBs strongly expressed these genes, the
expression of Oig2 was more prominent than that of other genes
in Shh/RA/noggin-EBs (Fig. 3D), assuming that cell identity may
be more restricted to the pMN domain. Shh/RA/noggin-EBs con-
tained a large number of cells expressing Olig1, another pMN do-
main marker, and a subset of these Olig1+ cells also expressed
Olig2 (Fig. 3E), while these cells were not detectable in control-
EBs (Fig. 3F). In addition, cells expressing two additional early oli-
godendrocyte markers, O4 and NG2, were frequently observed as
clusters in the Shh/RA/noggin-EBs at day 8 of EB formation
(Fig. 3G).
3.4. VN strongly enhances oligodendrocyte differentiation
Next, we tested whether VN treatment promotes the generation
of oligodendrocytes in the presence of Shh, RA, and noggin duringhESC differentiation. During neural differentiation, hESCs were
either treated with Shh/RA/noggin or not treated in the presence
or absence of VN. Surprisingly, the yield of O4+ oligodendrocytes
in the presence of Shh, RA, and noggin was signiﬁcantly increased,
with an additional 4-fold increase upon exposure to VN (Fig. 4A
and B). VN alone failed to increase the number of O4+ cells, sug-
gesting that VN and the three patterning molecules cooperatively
enhanced the differentiation of oligodendrocytes.3.5. Proliferation and differentiation of oligodendrocyte precursors
A recent study has demonstrated that PDFG treatment of bFGF-
expanded AC133+ CNS stem cells increases the number of Nestin+
cells that differentiate into O4+ oligodendrocytes in serum-free cul-
ture conditions [17]. We next examined the proliferative capacity
of OPCs, generated in the presence of Shh/RA/noggin plus VN, by
BrdU incorporation and immunostaining with NG2. As shown in
Fig. 5A and E, a large number of cells underwent cell death in the
absence of bFGF and PDGF, suggesting that bFGF and/or PDGF
may act as survival factors as well as mitogens. In contrast, treat-
ment with bFGF or PDGF signiﬁcantly increased the number of
NG2+BrdU+ cells (Fig. 5B, C and E). Furthermore, the mitogenic
activity of bFGF was signiﬁcantly enhanced by the combined treat-
ment with PDGF (Fig. 5D and E; 34 ± 10% versus 53 ± 10% of total
J.-E. Gil et al. / FEBS Letters 583 (2009) 561–567 565cells in the bFGF and bFGF/PDGF-treated groups, respectively;
P < 0.05).Fig. 3. Caudoventral patterning of hESC-derived neurectoderm. (A) RT-PCR analysis of Ot
(brain marker) and HB9/TuJ1 (motor neuron markers). The numbers of Otx2+ or HB9+ ce
control. (D) RT-PCR analysis of genes involved in neural tube ventral patterning. Noggin,
images of Olig1 and Olig2 in SRN-treated EBs. Double-immunostaining images of the bo
cells is shown as a percentage of total DAPI+ cells in the indicated conditions. *P < 0.05 ver
left panel; O4 and NG2, right panels) in SRN-treated EBs.
Fig. 4. Vitronectin-induced oligodendrocyte differentiation during neurogenesis of hESCs
cells per ﬁeld (10, n = 10) after the indicated treatments. Shh, S; RA, R; noggin, N; VN,Previous studies have demonstrated that newly formed oligo-
dendrocytes are sensitive to apoptosis and require multiple trophicx2 and Hox genes in the indicated treatment of EBs. (B, C) Immunostaining for Otx2
lls are shown in (B) as a percentage of total cells in each condition. *P < 0.05 versus
N; Shh/noggin, S/N; RA/noggin, R/N; Shh/RA/noggin, S/R/N. (E) Immunoﬂuorescence
xed area are shown in the right panels separately. (F) The number of Olig1+/Olig2+
sus control. (G) Immunoﬂuorescence labeling of early oligodendrocyte markers (O4,
. (A) Immunostaining for O4 after the indicated treatments. (B) Mean number of O4+
vitronectin. *P < 0.05 versus control. **P < 0.05 versus S/R/N.
Fig. 5. Effect of mitogenic and survival factors on the proliferation and differentiation of oligodendrocyte progenitors. (A–D) BrdU and NG2 double-immunostaining after the
indicated mitogen treatments for 8 days. (E) The numbers of NG2+/BrdU+ OPCs grown in each treatment groups were counted in 20 random ﬁelds and shown as percentages
of DAPI+ cells. *P < 0.05 versus control. **P < 0.05 versus bFGF. (F, G) Immunostaining for O4 and CNPase after differentiation. (H) RT-PCR analyses for markers of
undifferentiated hESCs (Oct4/Nanog), oligodendrocyte progenitors (NG2), and myelin-associated protein (PLP and MBP).
566 J.-E. Gil et al. / FEBS Letters 583 (2009) 561–567factors to survive in culture [18,19]. To avoid cell death, we further
differentiated hESC-derived OPCs toward oligodendrocytes for 8–
9 days in the presence or absence of survival factors cAMP, IGF-1,
and NT-3 [20–22]. As expected, OPCs cultured without any exoge-
nous mitogenic and survival signals generated O4+ oligodendro-
cytes in very low yields (8 ± 2%). Because the numbers of OPCs
were markedly increased by treatment with bFGF and PDGF, high
efﬁciencies of oligodendrocyte generation were achieved by pre-
treatment of OPCs with these two factors (50 ± 3%, P < 0.05 versus
control). The yield of O4+ cells was further increased (60 ± 3%,
P < 0.05 versus bFGF/PDGF-treated group) when the cells were dif-
ferentiated in the presence of cAMP, IGF-1, and NT-3 (Fig. 5F), sug-
gesting that these factors have contributed to the survival of the
differentiating hESC-derived oligodendrocytes. We also observed
many cells producing CNPase, a prenylated myelin protein that is
highly expressed in mature oligodendrocytes [23] (Fig. 5G). In
addition, expression of CNPase, MBP (myelin basic protein), and
PLP (proteolipid protein), all of which are major constituents of
myelin, were detected, although MBP was expressed at low level
(Fig. 5H). In contrast, markers of undifferentiated hESCs (Oct4
and Nanog) and oligodendrocyte progenitors (NG2) were nearly
undetectable after differentiation, although long-term in vivo stud-
ies are required to address the safety and efﬁcacy issues of hESC-
derived cells.In summary, we have demonstrated for the ﬁrst time to our
knowledge that hVN is expressed in the ventral part of developing
human spinal cord, and shown that VN can promote oligodendro-
cytic differentiation of hESCs. Although further studies are required
to understand the exact mechanism underlying the beneﬁcial ef-
fect of VN, our results provide an important basis for the develop-
ment of treatments for spinal cord injuries.Acknowledgments
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